Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Syros Pharmaceuticals Inc. (SYRS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

1,726,603 $15,228 +63% 10.06%
2.
Redmile Group

Jeremy Green

3,620,376 $33,525 +121% 0.94%
3.
Deerfield Management

James E. Flynn

1,268,946 $11,750 +1% 0.42%
4. 429,775 $3,980 0.36%
5.
EcoR1 Capital

Oleg Nodelman

248,480 $2,301 0.23%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$7.50 533,332 Director 1,593,270 2019-04-09 Filing
$9.55 209,424 Director 1,059,938 2018-01-31 Filing
$9.08 15,000 Officer 15,000 2017-12-15 Filing
$8.99 26,600 Director 830,494 2017-12-14 Filing
$8.97 68,400 Director 803,894 2017-12-13 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$10.00 22,700 Director 395,101 2019-08-16 Filing
$10.00 2,300 Director 417,801 2019-08-15 Filing
$7.70 34,521 Large Shareholder 4,242,051 2019-07-17 Filing
$7.81 25,779 Large Shareholder 4,276,572 2019-07-16 Filing
$8.27 2,700 Large Shareholder 4,302,051 2019-07-15 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 3,204,437 $29,673 1.28%
2. 3,791,756 $35,112 0.88%
3. 2,987,763 $27,667 0.54%
4. 20,070 $186 0.02%
5. 169,000 $1,558 0.01%